S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.42 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.42 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.42 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.42 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
NASDAQ:MSAC

Medicus Sciences Acquisition Stock Forecast, Price & News

$9.66
-0.02 (-0.21%)
(As of 01/28/2022 11:31 AM ET)
Add
Compare
Today's Range
$9.66
$9.66
50-Day Range
$9.66
$9.75
52-Week Range
$9.58
$10.29
Volume
1,504 shs
Average Volume
12,689 shs
Market Capitalization
$112.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive MSAC News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.


About Medicus Sciences Acquisition

Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:MSAC
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.01 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$112.20 million
Optionable
Not Optionable

Company Calendar

Today
1/28/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

0.33 out of 5 stars

Unclassified Sector

235th out of 637 stocks

Holding & Other Investment Offices Industry

229th out of 594 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Medicus Sciences Acquisition (NASDAQ:MSAC) Frequently Asked Questions

Are investors shorting Medicus Sciences Acquisition?

Medicus Sciences Acquisition saw a decrease in short interest in January. As of January 15th, there was short interest totaling 600 shares, a decrease of 14.3% from the December 31st total of 700 shares. Based on an average daily trading volume, of 17,700 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.
View Medicus Sciences Acquisition's Short Interest
.

Who are Medicus Sciences Acquisition's key executives?

Medicus Sciences Acquisition's management team includes the following people:
  • Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D., Exec. Chairman (Age 49)
  • Dr. Michael Bernard Castor M.D., CEO & Director (Age 50)
  • Dr. Judah Zvi Drillick CPA, Chief Financial Officer (Age 44)
  • Mr. Eric B. Cheng M.B.A., Chief Bus. Officer (Age 51)

What is Medicus Sciences Acquisition's stock symbol?

Medicus Sciences Acquisition trades on the NASDAQ under the ticker symbol "MSAC."

Who are Medicus Sciences Acquisition's major shareholders?

Medicus Sciences Acquisition's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Cantor Fitzgerald Investment Adviser L.P. (0.85%).

Which institutional investors are buying Medicus Sciences Acquisition stock?

MSAC stock was acquired by a variety of institutional investors in the last quarter, including Cantor Fitzgerald Investment Adviser L.P..

How do I buy shares of Medicus Sciences Acquisition?

Shares of MSAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medicus Sciences Acquisition's stock price today?

One share of MSAC stock can currently be purchased for approximately $9.66.

How much money does Medicus Sciences Acquisition make?

Medicus Sciences Acquisition has a market capitalization of $112.20 million.

What is Medicus Sciences Acquisition's official website?

The official website for Medicus Sciences Acquisition is www.medicusspac.com.

How can I contact Medicus Sciences Acquisition?

The company can be reached via phone at 212-259-8400.


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.